
Tirzepatide
Injectable Pen
Dual-targeted GLP-1 and GIP receptor agonist delivering clinically validated glycemic control and significant weight reduction.
- Slows gastric emptying for prolonged satiety and appetite control
- Robust glycemic control and metabolic regulation in T2DM
- Highly documented safety profile across global clinical studies


